Neogen Corporation (NASDAQ: NEOG) Stock Competitors & Peer Comparison
See NEOG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NEOG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NEOG | $11.85 | +1.46% | 2.6B | 41.82 | $0.28 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $99.60 | +0.88% | 170.4B | 18.91 | $5.21 | +2.49% |
| MDT | $88.48 | +3.47% | 112.3B | 15.86 | $5.53 | +3.23% |
| SYK | $277.33 | +0.70% | 106.2B | 20.69 | $13.39 | +1.27% |
| BSX | $42.73 | +2.77% | 62.5B | 13.56 | $3.10 | N/A |
| EW | $85.21 | -0.66% | 48.5B | 31.19 | $2.70 | N/A |
| DXCM | $84.11 | -0.23% | 31.9B | 33.10 | $2.55 | N/A |
| GEHC | $65.74 | +1.65% | 29B | 14.08 | $4.56 | +0.21% |
| PHG | $24.24 | +0.62% | 23.8B | 13.89 | $1.75 | +4.09% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
NEOG vs BSX-PA Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, NEOG's ROE is -0.03%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, NEOG is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
NEOG vs ABT Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ABT has a market cap of 170.4B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ABT trades at $99.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ABT's P/E ratio is 18.91. In terms of profitability, NEOG's ROE is -0.03%, compared to ABT's ROE of +0.11%. Regarding short-term risk, NEOG is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ABT's competition here
Medtronic Plc (NYSE: MDT)
NEOG vs MDT Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, MDT has a market cap of 112.3B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while MDT trades at $88.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas MDT's P/E ratio is 15.86. In terms of profitability, NEOG's ROE is -0.03%, compared to MDT's ROE of +0.11%. Regarding short-term risk, NEOG is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
NEOG vs SYK Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SYK has a market cap of 106.2B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while SYK trades at $277.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas SYK's P/E ratio is 20.69. In terms of profitability, NEOG's ROE is -0.03%, compared to SYK's ROE of +0.16%. Regarding short-term risk, NEOG is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
NEOG vs BSX Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BSX has a market cap of 62.5B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while BSX trades at $42.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas BSX's P/E ratio is 13.56. In terms of profitability, NEOG's ROE is -0.03%, compared to BSX's ROE of +0.15%. Regarding short-term risk, NEOG is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
NEOG vs EW Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, EW has a market cap of 48.5B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while EW trades at $85.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas EW's P/E ratio is 31.19. In terms of profitability, NEOG's ROE is -0.03%, compared to EW's ROE of +0.10%. Regarding short-term risk, NEOG is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
NEOG vs DXCM Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, DXCM has a market cap of 31.9B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while DXCM trades at $84.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas DXCM's P/E ratio is 33.10. In terms of profitability, NEOG's ROE is -0.03%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, NEOG is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
NEOG vs GEHC Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, GEHC has a market cap of 29B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while GEHC trades at $65.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas GEHC's P/E ratio is 14.08. In terms of profitability, NEOG's ROE is -0.03%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, NEOG is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
NEOG vs PHG Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PHG has a market cap of 23.8B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while PHG trades at $24.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas PHG's P/E ratio is 13.89. In terms of profitability, NEOG's ROE is -0.03%, compared to PHG's ROE of +0.10%. Regarding short-term risk, NEOG is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
NEOG vs ZBH Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ZBH has a market cap of 17.2B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ZBH trades at $89.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ZBH's P/E ratio is 10.48. In terms of profitability, NEOG's ROE is -0.03%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, NEOG is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
NEOG vs ABMD Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ABMD's P/E ratio is 65.36. In terms of profitability, NEOG's ROE is -0.03%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, NEOG is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ABMD's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
NEOG vs SWAV Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas SWAV's P/E ratio is 78.76. In terms of profitability, NEOG's ROE is -0.03%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, NEOG is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
NEOG vs PEN Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PEN has a market cap of 12.5B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while PEN trades at $319.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas PEN's P/E ratio is 82.88. In terms of profitability, NEOG's ROE is -0.03%, compared to PEN's ROE of +0.11%. Regarding short-term risk, NEOG is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
NEOG vs SNN Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SNN has a market cap of 11.3B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while SNN trades at $27.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas SNN's P/E ratio is 18.20. In terms of profitability, NEOG's ROE is -0.03%, compared to SNN's ROE of +0.12%. Regarding short-term risk, NEOG is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SNN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
NEOG vs BIO-B Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BIO-B has a market cap of 10.4B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while BIO-B trades at $380.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas BIO-B's P/E ratio is -66.99. In terms of profitability, NEOG's ROE is -0.03%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, NEOG is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BIO-B's competition here
Align Technology, Inc. (NASDAQ: ALGN)
NEOG vs ALGN Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ALGN has a market cap of 10.1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ALGN trades at $142.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ALGN's P/E ratio is 12.86. In terms of profitability, NEOG's ROE is -0.03%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, NEOG is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
NEOG vs GMED Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, GMED has a market cap of 9.9B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while GMED trades at $74.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas GMED's P/E ratio is 16.52. In terms of profitability, NEOG's ROE is -0.03%, compared to GMED's ROE of +0.12%. Regarding short-term risk, NEOG is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check GMED's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
NEOG vs BIO Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BIO has a market cap of 9.7B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while BIO trades at $366.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas BIO's P/E ratio is 38.82. In terms of profitability, NEOG's ROE is -0.03%, compared to BIO's ROE of +0.03%. Regarding short-term risk, NEOG is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BIO's competition here
Glaukos Corporation (NYSE: GKOS)
NEOG vs GKOS Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, GKOS has a market cap of 9.5B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while GKOS trades at $165.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas GKOS's P/E ratio is -187.57. In terms of profitability, NEOG's ROE is -0.03%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, NEOG is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check GKOS's competition here
Masimo Corporation (NASDAQ: MASI)
NEOG vs MASI Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas MASI's P/E ratio is 44.43. In terms of profitability, NEOG's ROE is -0.03%, compared to MASI's ROE of +0.09%. Regarding short-term risk, NEOG is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check MASI's competition here
Insulet Corp. (NASDAQ: PODD)
NEOG vs PODD Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PODD has a market cap of 9.3B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while PODD trades at $135.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas PODD's P/E ratio is 22.91. In terms of profitability, NEOG's ROE is -0.03%, compared to PODD's ROE of +0.27%. Regarding short-term risk, NEOG is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check PODD's competition here
Bruker Corporation (NASDAQ: BRKR)
NEOG vs BRKR Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BRKR has a market cap of 8.8B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while BRKR trades at $58.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas BRKR's P/E ratio is 29.11. In terms of profitability, NEOG's ROE is -0.03%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, NEOG is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
NEOG vs BRKRP Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BRKRP has a market cap of 8.6B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while BRKRP trades at $432.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas BRKRP's P/E ratio is 232.43. In terms of profitability, NEOG's ROE is -0.03%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, NEOG is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
NEOG vs HAE Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, HAE has a market cap of 5.4B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while HAE trades at $118.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas HAE's P/E ratio is 23.87. In terms of profitability, NEOG's ROE is -0.03%, compared to HAE's ROE of +0.11%. Regarding short-term risk, NEOG is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
NEOG vs NARI Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas NARI's P/E ratio is -59.24. In terms of profitability, NEOG's ROE is -0.03%, compared to NARI's ROE of -0.00%. Regarding short-term risk, NEOG is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
NEOG vs ITGR Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ITGR trades at $126.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ITGR's P/E ratio is 19.94. In terms of profitability, NEOG's ROE is -0.03%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, NEOG is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
NEOG vs LIVN Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while LIVN trades at $76.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas LIVN's P/E ratio is 18.03. In terms of profitability, NEOG's ROE is -0.03%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, NEOG is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check LIVN's competition here
Axonics, Inc. (NASDAQ: AXNX)
NEOG vs AXNX Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas AXNX's P/E ratio is -709.80. In terms of profitability, NEOG's ROE is -0.03%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, NEOG is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check AXNX's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
NEOG vs IRTC Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, IRTC has a market cap of 3.4B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while IRTC trades at $106.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas IRTC's P/E ratio is -238.60. In terms of profitability, NEOG's ROE is -0.03%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, NEOG is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check IRTC's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
NEOG vs TMDX Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, TMDX has a market cap of 2.7B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while TMDX trades at $77.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas TMDX's P/E ratio is 40.10. In terms of profitability, NEOG's ROE is -0.03%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, NEOG is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check TMDX's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
NEOG vs UFPT Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while UFPT trades at $288.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas UFPT's P/E ratio is 29.27. In terms of profitability, NEOG's ROE is -0.03%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, NEOG is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
NEOG vs BFLY Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BFLY has a market cap of 2.1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while BFLY trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas BFLY's P/E ratio is -33.42. In terms of profitability, NEOG's ROE is -0.03%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, NEOG is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check BFLY's competition here
NuVasive, Inc. (NASDAQ: NUVA)
NEOG vs NUVA Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas NUVA's P/E ratio is 75.00. In terms of profitability, NEOG's ROE is -0.03%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, NEOG is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check NUVA's competition here
AxoGen, Inc. (NASDAQ: AXGN)
NEOG vs AXGN Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AXGN has a market cap of 1.9B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while AXGN trades at $36.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas AXGN's P/E ratio is 95.21. In terms of profitability, NEOG's ROE is -0.03%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, NEOG is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check AXGN's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
NEOG vs INSP Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, INSP has a market cap of 1.9B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while INSP trades at $68.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas INSP's P/E ratio is 29.39. In terms of profitability, NEOG's ROE is -0.03%, compared to INSP's ROE of +0.18%. Regarding short-term risk, NEOG is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check INSP's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
NEOG vs ESTA Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ESTA has a market cap of 1.8B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ESTA trades at $61.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ESTA's P/E ratio is -48.10. In terms of profitability, NEOG's ROE is -0.03%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, NEOG is more volatile compared to ESTA. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
NEOG vs NVCR Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, NVCR has a market cap of 1.7B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while NVCR trades at $14.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas NVCR's P/E ratio is -10.94. In terms of profitability, NEOG's ROE is -0.03%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, NEOG is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
NEOG vs ATEC Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ATEC has a market cap of 1.6B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ATEC trades at $10.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ATEC's P/E ratio is -172.50. In terms of profitability, NEOG's ROE is -0.03%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, NEOG is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
NEOG vs CNMD Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while CNMD trades at $44.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas CNMD's P/E ratio is 9.92. In terms of profitability, NEOG's ROE is -0.03%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, NEOG is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
NEOG vs HSKA Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas HSKA's P/E ratio is -62.49. In terms of profitability, NEOG's ROE is -0.03%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, NEOG is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check HSKA's competition here
Avanos Medical, Inc. (NYSE: AVNS)
NEOG vs AVNS Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas AVNS's P/E ratio is 27.77. In terms of profitability, NEOG's ROE is -0.03%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, NEOG is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check AVNS's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
NEOG vs SILK Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas SILK's P/E ratio is -18.96. In terms of profitability, NEOG's ROE is -0.03%, compared to SILK's ROE of -0.35%. Regarding short-term risk, NEOG is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
NEOG vs FNA Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas FNA's P/E ratio is -19.83. In terms of profitability, NEOG's ROE is -0.03%, compared to FNA's ROE of -0.35%. Regarding short-term risk, NEOG is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
NEOG vs IRMD Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while IRMD trades at $87.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas IRMD's P/E ratio is 43.16. In terms of profitability, NEOG's ROE is -0.03%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, NEOG is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check IRMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
NEOG vs TNDM Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while TNDM trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas TNDM's P/E ratio is -16.85. In terms of profitability, NEOG's ROE is -0.03%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, NEOG is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check TNDM's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
NEOG vs IART Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, IART has a market cap of 1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while IART trades at $13.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas IART's P/E ratio is 5.68. In terms of profitability, NEOG's ROE is -0.03%, compared to IART's ROE of -0.01%. Regarding short-term risk, NEOG is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
NEOG vs AORT Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AORT has a market cap of 1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while AORT trades at $21.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas AORT's P/E ratio is 35.34. In terms of profitability, NEOG's ROE is -0.03%, compared to AORT's ROE of -0.01%. Regarding short-term risk, NEOG is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check AORT's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
NEOG vs PRCT Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PRCT has a market cap of 1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while PRCT trades at $18.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas PRCT's P/E ratio is -9.23. In terms of profitability, NEOG's ROE is -0.03%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, NEOG is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check PRCT's competition here
Enovis Corporation (NYSE: ENOV)
NEOG vs ENOV Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ENOV has a market cap of 1B. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ENOV trades at $17.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ENOV's P/E ratio is 5.00. In terms of profitability, NEOG's ROE is -0.03%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, NEOG is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ENOV's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
NEOG vs LMRI Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, LMRI has a market cap of 992.5M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while LMRI trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas LMRI's P/E ratio is -20.10. In terms of profitability, NEOG's ROE is -0.03%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, NEOG is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check LMRI's competition here
CeriBell, Inc. (NASDAQ: CBLL)
NEOG vs CBLL Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CBLL has a market cap of 878.4M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while CBLL trades at $23.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas CBLL's P/E ratio is -13.15. In terms of profitability, NEOG's ROE is -0.03%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, NEOG is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check CBLL's competition here
Bioventus Inc. (NASDAQ: BVS)
NEOG vs BVS Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BVS has a market cap of 859.7M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while BVS trades at $13.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas BVS's P/E ratio is 16.70. In terms of profitability, NEOG's ROE is -0.03%, compared to BVS's ROE of +0.28%. Regarding short-term risk, NEOG is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BVS's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
NEOG vs CSII Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas CSII's P/E ratio is -20.83. In terms of profitability, NEOG's ROE is -0.03%, compared to CSII's ROE of -0.14%. Regarding short-term risk, NEOG is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
NEOG vs SIBN Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SIBN has a market cap of 836.4M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while SIBN trades at $19.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas SIBN's P/E ratio is -55.47. In terms of profitability, NEOG's ROE is -0.03%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, NEOG is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SIBN's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
NEOG vs AHCO Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AHCO has a market cap of 825.2M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while AHCO trades at $6.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas AHCO's P/E ratio is 12.38. In terms of profitability, NEOG's ROE is -0.03%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, NEOG is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check AHCO's competition here
InMode Ltd. (NASDAQ: INMD)
NEOG vs INMD Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, INMD has a market cap of 809.3M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while INMD trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas INMD's P/E ratio is 9.78. In terms of profitability, NEOG's ROE is -0.03%, compared to INMD's ROE of +0.12%. Regarding short-term risk, NEOG is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check INMD's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
NEOG vs BBNX Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BBNX has a market cap of 784.2M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while BBNX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas BBNX's P/E ratio is -10.56. In terms of profitability, NEOG's ROE is -0.03%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, NEOG is more volatile compared to BBNX. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check BBNX's competition here
Varex Imaging Corporation (NASDAQ: VREX)
NEOG vs VREX Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, VREX has a market cap of 777.6M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while VREX trades at $18.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas VREX's P/E ratio is 19.44. In terms of profitability, NEOG's ROE is -0.03%, compared to VREX's ROE of +0.05%. Regarding short-term risk, NEOG is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check VREX's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
NEOG vs PACB Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PACB has a market cap of 714.4M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while PACB trades at $2.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas PACB's P/E ratio is -5.61. In terms of profitability, NEOG's ROE is -0.03%, compared to PACB's ROE of -49.62%. Regarding short-term risk, NEOG is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check PACB's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
NEOG vs CTKB Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CTKB has a market cap of 692.2M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while CTKB trades at $5.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas CTKB's P/E ratio is -28.40. In terms of profitability, NEOG's ROE is -0.03%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, NEOG is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check CTKB's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
NEOG vs AVR Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, AVR has a market cap of 644.6M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while AVR trades at $6.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas AVR's P/E ratio is -3.42. In terms of profitability, NEOG's ROE is -0.03%, compared to AVR's ROE of -0.78%. Regarding short-term risk, NEOG is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check AVR's competition here
Surmodics, Inc. (NASDAQ: SRDX)
NEOG vs SRDX Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas SRDX's P/E ratio is -34.66. In terms of profitability, NEOG's ROE is -0.03%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, NEOG is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SRDX's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
NEOG vs APEN Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas APEN's P/E ratio is -9.43. In terms of profitability, NEOG's ROE is -0.03%, compared to APEN's ROE of -0.85%. Regarding short-term risk, NEOG is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
NEOG vs KIDS Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, KIDS has a market cap of 558.9M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while KIDS trades at $21.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas KIDS's P/E ratio is -18.44. In terms of profitability, NEOG's ROE is -0.03%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, NEOG is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check KIDS's competition here
ZimVie Inc. (NASDAQ: ZIMV)
NEOG vs ZIMV Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, NEOG's ROE is -0.03%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, NEOG is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ZIMV's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
NEOG vs SSII Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SSII has a market cap of 532.3M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while SSII trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas SSII's P/E ratio is -44.33. In terms of profitability, NEOG's ROE is -0.03%, compared to SSII's ROE of -0.27%. Regarding short-term risk, NEOG is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check SSII's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
NEOG vs DCTH Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, DCTH has a market cap of 519.2M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while DCTH trades at $15.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas DCTH's P/E ratio is 1504.00. In terms of profitability, NEOG's ROE is -0.03%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, NEOG is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check DCTH's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
NEOG vs TCMD Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, TCMD has a market cap of 498.9M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while TCMD trades at $22.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas TCMD's P/E ratio is 20.48. In terms of profitability, NEOG's ROE is -0.03%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, NEOG is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check TCMD's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
NEOG vs SGHT Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SGHT has a market cap of 460.9M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while SGHT trades at $8.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas SGHT's P/E ratio is -15.12. In terms of profitability, NEOG's ROE is -0.03%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, NEOG is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check SGHT's competition here
Cerus Corporation (NASDAQ: CERS)
NEOG vs CERS Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CERS has a market cap of 459.5M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while CERS trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas CERS's P/E ratio is -75.75. In terms of profitability, NEOG's ROE is -0.03%, compared to CERS's ROE of -0.10%. Regarding short-term risk, NEOG is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
NEOG vs NPCE Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, NPCE has a market cap of 422.4M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while NPCE trades at $12.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas NPCE's P/E ratio is -21.74. In terms of profitability, NEOG's ROE is -0.03%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, NEOG is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check NPCE's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
NEOG vs SENS Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SENS has a market cap of 377M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while SENS trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas SENS's P/E ratio is -4.04. In terms of profitability, NEOG's ROE is -0.03%, compared to SENS's ROE of -1.66%. Regarding short-term risk, NEOG is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
NEOG vs OFIX Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, OFIX has a market cap of 363.8M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while OFIX trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas OFIX's P/E ratio is -5.86. In terms of profitability, NEOG's ROE is -0.03%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, NEOG is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check OFIX's competition here
Avita Medical Inc. (NASDAQ: RCEL)
NEOG vs RCEL Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, RCEL has a market cap of 331.2M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while RCEL trades at $13.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas RCEL's P/E ratio is -9.26. In terms of profitability, NEOG's ROE is -0.03%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, NEOG is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check RCEL's competition here
CapsoVision, Inc. (NASDAQ: CV)
NEOG vs CV Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CV has a market cap of 330.8M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while CV trades at $6.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas CV's P/E ratio is -10.51. In terms of profitability, NEOG's ROE is -0.03%, compared to CV's ROE of -1.78%. Regarding short-term risk, NEOG is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check CV's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
NEOG vs CLPT Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CLPT has a market cap of 314.6M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while CLPT trades at $10.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas CLPT's P/E ratio is -8.89. In terms of profitability, NEOG's ROE is -0.03%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, NEOG is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check CLPT's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
NEOG vs SMLR Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas SMLR's P/E ratio is 3.92. In terms of profitability, NEOG's ROE is -0.03%, compared to SMLR's ROE of +0.20%. Regarding short-term risk, NEOG is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check SMLR's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
NEOG vs CATX Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, CATX has a market cap of 309.1M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while CATX trades at $2.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas CATX's P/E ratio is -2.04. In terms of profitability, NEOG's ROE is -0.03%, compared to CATX's ROE of -0.42%. Regarding short-term risk, NEOG is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check CATX's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
NEOG vs INFU Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, INFU has a market cap of 271M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while INFU trades at $13.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas INFU's P/E ratio is 32.76. In terms of profitability, NEOG's ROE is -0.03%, compared to INFU's ROE of +0.15%. Regarding short-term risk, NEOG is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check INFU's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
NEOG vs TLSI Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, TLSI has a market cap of 254.3M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while TLSI trades at $4.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas TLSI's P/E ratio is -2.46. In terms of profitability, NEOG's ROE is -0.03%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, NEOG is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check TLSI's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
NEOG vs TMCI Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, TMCI has a market cap of 251.4M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while TMCI trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas TMCI's P/E ratio is -4.12. In terms of profitability, NEOG's ROE is -0.03%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, NEOG is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check TMCI's competition here
Profound Medical Corp. (NASDAQ: PROF)
NEOG vs PROF Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, PROF has a market cap of 251.1M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while PROF trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas PROF's P/E ratio is -7.05. In terms of profitability, NEOG's ROE is -0.03%, compared to PROF's ROE of -0.56%. Regarding short-term risk, NEOG is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check PROF's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
NEOG vs MGRM Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas MGRM's P/E ratio is -12.00. In terms of profitability, NEOG's ROE is -0.03%, compared to MGRM's ROE of -1.17%. Regarding short-term risk, NEOG is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check MGRM's competition here
Quantum-Si incorporated (NASDAQ: QSI)
NEOG vs QSI Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, QSI has a market cap of 241.3M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while QSI trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas QSI's P/E ratio is -2.65. In terms of profitability, NEOG's ROE is -0.03%, compared to QSI's ROE of -0.47%. Regarding short-term risk, NEOG is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check QSI's competition here
Electromed, Inc. (AMEX: ELMD)
NEOG vs ELMD Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ELMD has a market cap of 230.4M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ELMD trades at $27.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ELMD's P/E ratio is 21.24. In terms of profitability, NEOG's ROE is -0.03%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, NEOG is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
NEOG vs NVRO Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas NVRO's P/E ratio is -1.91. In terms of profitability, NEOG's ROE is -0.03%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, NEOG is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check NVRO's competition here
RxSight, Inc. (NASDAQ: RXST)
NEOG vs RXST Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, RXST has a market cap of 200.8M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while RXST trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas RXST's P/E ratio is -4.29. In terms of profitability, NEOG's ROE is -0.03%, compared to RXST's ROE of -0.17%. Regarding short-term risk, NEOG is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check RXST's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
NEOG vs BSGM Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas BSGM's P/E ratio is -5.81. In terms of profitability, NEOG's ROE is -0.03%, compared to BSGM's ROE of +6.96%. Regarding short-term risk, NEOG is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
NEOG vs MDGS Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas MDGS's P/E ratio is -0.27. In terms of profitability, NEOG's ROE is -0.03%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, NEOG is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
NEOG vs QIPT Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas QIPT's P/E ratio is -15.87. In terms of profitability, NEOG's ROE is -0.03%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, NEOG is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
NEOG vs INGN Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, INGN has a market cap of 160.8M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while INGN trades at $6.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas INGN's P/E ratio is -6.53. In terms of profitability, NEOG's ROE is -0.03%, compared to INGN's ROE of -0.13%. Regarding short-term risk, NEOG is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check INGN's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
NEOG vs FOCL Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, FOCL has a market cap of 154.6M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while FOCL trades at $4.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas FOCL's P/E ratio is -3.99. In terms of profitability, NEOG's ROE is -0.03%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, NEOG is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check FOCL's competition here
Quanterix Corporation (NASDAQ: QTRX)
NEOG vs QTRX Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, QTRX has a market cap of 151.2M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while QTRX trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas QTRX's P/E ratio is -1.26. In terms of profitability, NEOG's ROE is -0.03%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, NEOG is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check QTRX's competition here
Neuronetics, Inc. (NASDAQ: STIM)
NEOG vs STIM Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, STIM has a market cap of 148.9M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while STIM trades at $2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas STIM's P/E ratio is -4.86. In terms of profitability, NEOG's ROE is -0.03%, compared to STIM's ROE of -1.51%. Regarding short-term risk, NEOG is more volatile compared to STIM. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check STIM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
NEOG vs LUCD Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, LUCD has a market cap of 124M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while LUCD trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas LUCD's P/E ratio is -1.76. In terms of profitability, NEOG's ROE is -0.03%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, NEOG is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check LUCD's competition here
iCAD, Inc. (NASDAQ: ICAD)
NEOG vs ICAD Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ICAD's P/E ratio is -20.37. In terms of profitability, NEOG's ROE is -0.03%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, NEOG is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
NEOG vs HJLI Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas HJLI's P/E ratio is N/A. In terms of profitability, NEOG's ROE is -0.03%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, NEOG is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for NEOG.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
NEOG vs ASXC Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ASXC's P/E ratio is -1.12. In terms of profitability, NEOG's ROE is -0.03%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, NEOG is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ASXC's competition here
electroCore, Inc. (NASDAQ: ECOR)
NEOG vs ECOR Comparison October 2026
Neogen Corporation (NASDAQ: NEOG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEOG stands at 2.6B. In comparison, ECOR has a market cap of 85.7M. Regarding current trading prices, NEOG is priced at $11.85 on the NASDAQ, while ECOR trades at $9.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEOG currently has a P/E ratio of 41.82, whereas ECOR's P/E ratio is -5.66. In terms of profitability, NEOG's ROE is -0.03%, compared to ECOR's ROE of +5.25%. Regarding short-term risk, NEOG is more volatile compared to ECOR. This indicates higher risk in terms of short-term price fluctuations for NEOG.Check ECOR's competition here